Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Proliferative Vitreoretinopathy With Intravitreal Infliximab

NCT04891991 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04891991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04891991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Proliferative Vitreoretinopathy With Intravitreal Infliximab
Lead sponsor
Cairo University
Phase
Phase 2
Overall status
Completed
Start date
November 26, 2021
Completion date
November 10, 2023
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative vitreoretinopathy, retinal detachment, rhegmatogenous retinal detachment